MASS Stock Overview
A commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
908 Devices Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.06 |
| 52 Week High | US$12.51 |
| 52 Week Low | US$1.82 |
| Beta | 0.91 |
| 1 Month Change | -19.53% |
| 3 Month Change | -41.14% |
| 1 Year Change | -77.92% |
| 3 Year Change | -92.27% |
| 5 Year Change | n/a |
| Change since IPO | -95.80% |
Recent News & Updates
Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts
Nov 15
908 Devices: Key Investor Now Selling
Sep 08Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge
Aug 16Recent updates
Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts
Nov 15908 Devices: Key Investor Now Selling
Sep 08Why We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge
Aug 16We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth
Mar 30Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects
Dec 18908 Devices Q2 2022 Earnings Preview
Aug 08908 Devices Aims For Broadened Footprint
Feb 02Shareholder Returns
| MASS | US Electronic | US Market | |
|---|---|---|---|
| 7D | -1.0% | -3.1% | -2.4% |
| 1Y | -77.9% | 17.7% | 23.4% |
Return vs Industry: MASS underperformed the US Electronic industry which returned 17.6% over the past year.
Return vs Market: MASS underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| MASS volatility | |
|---|---|
| MASS Average Weekly Movement | 12.3% |
| Electronic Industry Average Movement | 6.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MASS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MASS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 230 | Kevin Knopp | 908devices.com |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.
908 Devices Inc. Fundamentals Summary
| MASS fundamental statistics | |
|---|---|
| Market cap | US$71.74m |
| Earnings (TTM) | -US$60.19m |
| Revenue (TTM) | US$55.16m |
1.3x
P/S Ratio-1.2x
P/E RatioIs MASS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MASS income statement (TTM) | |
|---|---|
| Revenue | US$55.16m |
| Cost of Revenue | US$27.13m |
| Gross Profit | US$28.03m |
| Other Expenses | US$88.22m |
| Earnings | -US$60.19m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.73 |
| Gross Margin | 50.81% |
| Net Profit Margin | -109.11% |
| Debt/Equity Ratio | 0% |
How did MASS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:38 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
908 Devices Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Puneet Souda | Leerink Partners LLC |
| Jacob Johnson | Stephens, Inc. |
| Daniel Arias | Stifel, Equities Research |